JP2009524692A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009524692A5 JP2009524692A5 JP2008552581A JP2008552581A JP2009524692A5 JP 2009524692 A5 JP2009524692 A5 JP 2009524692A5 JP 2008552581 A JP2008552581 A JP 2008552581A JP 2008552581 A JP2008552581 A JP 2008552581A JP 2009524692 A5 JP2009524692 A5 JP 2009524692A5
- Authority
- JP
- Japan
- Prior art keywords
- registered trademark
- ophthalmic formulation
- subject
- tears
- formulation according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US76194506P | 2006-01-25 | 2006-01-25 | |
| PCT/US2007/061065 WO2007087609A2 (en) | 2006-01-25 | 2007-01-25 | Formulations and methods for treating dry eye |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009524692A JP2009524692A (ja) | 2009-07-02 |
| JP2009524692A5 true JP2009524692A5 (https=) | 2011-03-17 |
Family
ID=38309951
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008552581A Pending JP2009524692A (ja) | 2006-01-25 | 2007-01-25 | ドライアイのための処方物および方法 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20070254841A1 (https=) |
| EP (1) | EP1981491A4 (https=) |
| JP (1) | JP2009524692A (https=) |
| AU (1) | AU2007208054A1 (https=) |
| CA (1) | CA2636646A1 (https=) |
| WO (1) | WO2007087609A2 (https=) |
Families Citing this family (20)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2534484A1 (en) * | 2003-08-07 | 2005-02-17 | Allergan, Inc. | Compositions for delivery of therapeutics into the eyes and methods for making and using same |
| US8748402B2 (en) | 2004-06-07 | 2014-06-10 | Bausch & Lomb Pharma Holdings Corp. | Ophthalmic formulations and uses thereof |
| US8372814B2 (en) * | 2004-06-07 | 2013-02-12 | Ista Pharmaceuticals, Inc. | Ophthalmic formulations and uses thereof |
| US8137111B2 (en) * | 2007-06-28 | 2012-03-20 | Eye Care And Cure Pte. Ltd | Model human eye |
| US9192571B2 (en) * | 2008-03-03 | 2015-11-24 | Allergan, Inc. | Ketorolac tromethamine compositions for treating or preventing ocular pain |
| US7842714B2 (en) * | 2008-03-03 | 2010-11-30 | Allergan, Inc. | Ketorolac tromethamine compositions for treating ocular pain |
| AU2009202969B1 (en) * | 2009-07-23 | 2009-11-19 | Allergan, Inc. | Ketorolac tromethamine compositions for treating or preventing ocular pain |
| US8778999B2 (en) * | 2009-03-05 | 2014-07-15 | Insite Vision Incorporated | Non-steroidal anti-inflammatory ophthalmic compositions |
| US8921337B2 (en) | 2009-12-03 | 2014-12-30 | Alcon Research, Ltd. | Carboxyvinyl polymer-containing nanoparticle suspensions |
| EP2555770B1 (en) * | 2010-04-09 | 2017-11-01 | Allergan, Inc. | Ketorolac compositions for corneal wound healing |
| US8684743B2 (en) | 2010-07-23 | 2014-04-01 | Eye Care And Cure Pte. Ltd | Model human eye and face manikin for use therewith |
| CN102557976B (zh) * | 2010-12-15 | 2015-06-10 | 辽宁盛京制药有限公司 | 溴芬酸有机盐及其制备方法、其组合物及用途 |
| MX346312B (es) * | 2011-04-05 | 2017-03-15 | Optosolve Res & Dev Ltd | Tratamientos oftalmicos. |
| US20130023575A1 (en) * | 2011-07-22 | 2013-01-24 | Kamran Hosseini | Compositions and methods for the treatment of ocular surface allergies |
| US9630909B2 (en) | 2013-06-27 | 2017-04-25 | Mylan Laboratories Ltd | Process for the preparation of nepafenac |
| EP4137139A1 (en) | 2013-07-10 | 2023-02-22 | Matrix Biology Institute | Compositions of hyaluronan with high elasticity and uses thereof |
| KR102268536B1 (ko) * | 2013-12-25 | 2021-06-23 | 가부시키가이샤 엘티티 바이오파마 | 드라이아이 치료용 점안제 |
| US9775861B1 (en) * | 2014-09-26 | 2017-10-03 | Paul S. Jensen | Dry eye composition and method for preparing the composition |
| PL3352766T3 (pl) | 2015-09-24 | 2021-08-02 | Matrix Biology Institute | Kompozycie z hialuronanem o dużej elastyczności i sposoby ich użycia |
| US20240315995A1 (en) * | 2021-07-09 | 2024-09-26 | Guangzhou Ocusun Ophthalmic Biotechnology Co., Ltd. | Application of loxoprofen sodium in preparation of drug for treating dry eye disease |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4230724A (en) * | 1979-07-16 | 1980-10-28 | Allergan Pharmaceuticals, Inc. | Method of treating vascularization of the eye with Flurbiprofen |
| US4407791A (en) * | 1981-09-28 | 1983-10-04 | Alcon Laboratories, Inc. | Ophthalmic solutions |
| US4454151A (en) * | 1982-03-22 | 1984-06-12 | Syntex (U.S.A.) Inc. | Use of pyrrolo pyrroles in treatment of ophthalmic diseases |
| DE3612537C1 (de) * | 1986-04-14 | 1987-07-16 | Dispersa Ag | Arzneimittel zur Behandlung von Entzuendungen im Auge |
| US5110493A (en) * | 1987-09-11 | 1992-05-05 | Syntex (U.S.A.) Inc. | Ophthalmic NSAID formulations containing a quaternary ammonium preservative and a nonionic surfactant |
| CA1325382C (en) * | 1988-01-27 | 1993-12-21 | Takahiro Ogawa | Locally administrable therapeutic composition for inflammatory disease |
| US4960799A (en) * | 1988-09-13 | 1990-10-02 | Ciba-Geigy Corporation | Stabilized aqueous solutions of pharmaceutically acceptable salts of ortho-(2,6-dichlorophenyl)-aminophenylacetic acid for opthalmic use |
| US5563972A (en) * | 1992-11-27 | 1996-10-08 | Siemens Aktiengesellschaft | Radio frequency shielding arrangement for a plug which has a light guide and can be connected to a module frame |
| US5475034A (en) * | 1994-06-06 | 1995-12-12 | Alcon Laboratories, Inc. | Topically administrable compositions containing 3-benzoylphenylacetic acid derivatives for treatment of ophthalmic inflammatory disorders |
| US5811446A (en) * | 1997-04-18 | 1998-09-22 | Cytos Pharmaceuticals Llc | Prophylactic and therapeutic methods for ocular degenerative diseases and inflammations and histidine compositions therefor |
| DK0999825T3 (da) * | 1997-07-29 | 2004-02-09 | Alcon Lab Inc | Oftalmiske sammensætninger indeholdende galactomannanpolymerer og borater |
| US6552020B1 (en) * | 1999-07-30 | 2003-04-22 | Allergan, Inc. | Compositions including antibiotics and methods for using same |
| EP1476135A1 (en) * | 2002-02-22 | 2004-11-17 | Pharmacia Corporation | Ophthalmic formulation with gum system |
| US6828356B2 (en) * | 2002-07-29 | 2004-12-07 | Ast Products, Inc. | Preparation of ophthalmic compositions |
| US6806364B2 (en) * | 2002-07-29 | 2004-10-19 | Ast Products, Inc. | Ophthalmic compositions |
| PT1586316E (pt) * | 2003-01-21 | 2008-05-28 | Senju Pharma Co | Preparação líquida aquosa contendo ácido 2-amino-3-(4- bromobenzoil)fenilacético |
| US20050239745A1 (en) * | 2004-03-03 | 2005-10-27 | Ophthalmic Research Associates, Inc. | Novel topical ophthalmic formulations |
| WO2005101982A2 (en) * | 2004-03-24 | 2005-11-03 | Sun Pharmaceutical Industries Limited | A stable ophthalmic composition |
| CA2607608A1 (en) * | 2005-05-10 | 2006-11-16 | Alcon, Inc. | Suspension formulations of nepafenac and other ophthalmic drugs for topical treatment of ophthalmic disorders |
-
2007
- 2007-01-25 AU AU2007208054A patent/AU2007208054A1/en not_active Abandoned
- 2007-01-25 JP JP2008552581A patent/JP2009524692A/ja active Pending
- 2007-01-25 WO PCT/US2007/061065 patent/WO2007087609A2/en not_active Ceased
- 2007-01-25 US US11/698,778 patent/US20070254841A1/en not_active Abandoned
- 2007-01-25 EP EP07717416A patent/EP1981491A4/en not_active Withdrawn
- 2007-01-25 CA CA002636646A patent/CA2636646A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009524692A5 (https=) | ||
| JP5140757B2 (ja) | 薬物徐放性ハイドロゲルコンタクトレンズ及び薬物徐放性ハイドロゲルコンタクトレンズを用いた薬物放出方法 | |
| TW200400055A (en) | Ophthalmic formulation with novel gum composition | |
| JP2024107166A (ja) | ドライアイ疾患を処置するための製剤 | |
| US20070297981A1 (en) | Formulations and methods for treating dry eye | |
| ES2301795T3 (es) | Forma de administracion transepicutanea para el tratamiento del sindrome de las piernas inquietas. | |
| US20090010850A1 (en) | Formulations and methods for treating dry eye | |
| JP2013035860A5 (https=) | ||
| US20070254841A1 (en) | Formulations and methods for treating dry eye | |
| JP2018522070A (ja) | 白内障の処置用組成物 | |
| JP2010533225A5 (https=) | ||
| EP2437602A1 (en) | Ophthalmic formulations, methods of manufacture, and methods of using same | |
| JP2010507686A5 (https=) | ||
| JP2011503061A (ja) | 浸透圧活性剤及び血管収縮剤を含む眼けん腫脹の治療及び防止のための組成物 | |
| MX2008012496A (es) | Formulaciones de farmacos anti-inflamatorios no esteroidales de baja dosis y beta-ciclodextrina. | |
| AU2007243334A1 (en) | Compositions for the treatment and prevention of eyelid swelling | |
| US20080039398A1 (en) | Formulations and methods for treating dry eye | |
| JP2016520653A5 (https=) | ||
| SK11093A3 (en) | Treatment of disease employing hyaluronic and nsaids | |
| TW201206418A (en) | Composition for prevention and treatment of contact lens papillary conjunctivitis and allergic eye disease | |
| US20070299124A1 (en) | Formulations and methods for treating dry eye | |
| Joshi et al. | Thin films: a promising approach for drug delivery system | |
| US10391074B2 (en) | Topical preparation for pain relief | |
| Griffith et al. | Human platelet lysate delivered via an ocular wound chamber for the treatment of corneal epithelial injuries | |
| Kaith et al. | Pullulan as a sustained release carrier for ocular drug delivery: a review |